Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Guided Therapeutics (GTHP) Dividends Paid - Common (2023 - 2024)

Guided Therapeutics (GTHP) has disclosed Dividends Paid - Common for 2 consecutive years, with $54824.0 as the latest value for Q2 2024.

  • Quarterly Dividends Paid - Common changed N/A to $54824.0 in Q2 2024 from the year-ago period, while the trailing twelve-month figure was $120120.0 through Jun 2024, up 83.96% year-over-year, with the annual reading at $65296.0 for FY2023, 45.64% down from the prior year.
  • Dividends Paid - Common hit $54824.0 in Q2 2024 for Guided Therapeutics, down from $65296.0 in the prior quarter.
  • In the past five years, Dividends Paid - Common ranged from a high of $65296.0 in Q1 2023 to a low of $54824.0 in Q2 2024.